CDKN2A-p53 mediated antitumor effect of Lupeol in head and neck cancer

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Cellular Oncology

• Publication date

  2017-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s13402-016-0311-7PMID 28039610PMCID PMC13001573
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inactivation of the LKB1-AMPK signaling pathway does not contribute to salivary gland tumor development - a short report

  2016cited by this paper
• Lupeol evokes anticancer effects in oral squamous cell carcinoma by inhibiting oncogenic EGFR pathway

  2016cited by this paper
• WT1, MSH6, GATA5 and PAX5 as epigenetic oral squamous cell carcinoma biomarkers - a short report

  2016cited by this paper
• Identification of miR-139-5p as a saliva biomarker for tongue squamous cell carcinoma: a pilot study

  2016cited by this paper
• Cancer therapy with phytochemicals: evidence from clinical studies

  2015cited by this paper
• Cannabis smoke can be a major risk factor for early-age laryngeal cancer—a molecular signaling-based approach

  2015cited by this paper
• Temporally sequenced anticancer drugs overcome adaptive resistance by targeting a vulnerable chemotherapy-induced phenotypic transition

  2015cited by this paper
• ECRG4 acts as a tumor suppressor and as a determinant of chemotherapy resistance in human nasopharyngeal carcinoma

  2015cited by this paper
• Predicting clinical response to anticancer drugs using an ex vivo platform that captures tumour heterogeneity

  2015cited by this paper
• Cell death mechanisms of plant-derived anticancer drugs: beyond apoptosis

  2015cited by this paper
• Senescence and aging: the critical roles of p53

  2013cited by this paper
• Chemotherapy and Dietary Phytochemical Agents

  2012cited by this paper
• Advances in Targeting HER3 as an Anticancer Therapy

  2012cited by this paper
• Cheminformatics-based selection and synergism of herbal extracts with anticancer agents on drug resistance tumor cells - ACHN and A2780/CP cell lines

  2011cited by this paper
• p53, Stem Cells, and Reprogramming: Tumor Suppression beyond Guarding the Genome.

  2011cited by this paper
• Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy

  2011cited by this paper
• Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer

  2010cited by this paper
• Indole-3-carbinol induces apoptosis through p53 and activation of caspase-8 pathway in lung cancer A549 cells.

  2010cited by this paper
• Curcumin inhibits the side population (SP) phenotype of the rat C6 glioma cell line: towards targeting of cancer stem cells with phytochemicals.

  2010cited by this paper
• Quantitative analysis of expression level of BCL2 and BAX genes in Hep-2 and HL-60 cells after treatment with etoposide.

  2008cited by this paper
• A dual role of p53 in the control of autophagy

  2008cited by this paper
• DNA damage and endoplasmic reticulum stress mediated curcumin-induced cell cycle arrest and apoptosis in human lung carcinoma A-549 cells through the activation caspases cascade- and mitochondrial-dependent pathway.

  2008cited by this paper
• Lupeol Inhibits Growth of Highly Aggressive Human Metastatic Melanoma Cells In vitro and In vivo by Inducing Apoptosis

  2008cited by this paper
• Cancer-derived p53 mutants suppress p53-target gene expression—potential mechanism for gain of function of mutant p53

  2007cited by this paper
• Expression of the IAP protein family is dysregulated in pancreatic cancer cells and is important for resistance to chemotherapy

  2007cited by this paper
• Apoptosis by dietary factors: the suicide solution for delaying cancer growth.

  2006cited by this paper
• The inhibitory mechanism of curcumin and its derivative against β‐catenin/Tcf signaling

  2005cited by this paper
• Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer.

  2004cited by this paper
• Curcumin impairs tumor suppressor p53 function in colon cancer cells.

  2004cited by this paper
• The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer

  2003cited by this paper
• PUMA mediates the apoptotic response to p53 in colorectal cancer cells

  2003cited by this paper
• The p53 pathway in breast cancer

  2002cited by this paper
• Inhibition of TRAIL-induced apoptosis by Bcl-2 overexpression

  2002cited by this paper
• Antiviral agent Cidofovir restores p53 function and enhances the radiosensitivity in HPV-associated cancers

  2002cited by this paper
• p53 Signaling and cell cycle checkpoints.

  2001cited by this paper
• Apoptosis Corralling the Corpses

  2001cited by this paper
• Development of cyclin-dependent kinase modulators as novel therapeutic approaches for hematological malignancies

  2001cited by this paper
• Activation and activities of the p53 tumour suppressor protein

  2001cited by this paper
• Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase.

  2001cited by this paper
• Two splicing variants of a new inhibitor of apoptosis gene with different biological properties and tissue distribution pattern

  2001cited by this paper
• Preclinical and clinical development of cyclin-dependent kinase modulators.

  2000cited by this paper
• ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas.

  2000cited by this paper
• Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases

  1999cited by this paper
• GADD45 induction of a G2/M cell cycle checkpoint.

  1999cited by this paper
• p21Waf1/Cip1 Inhibition of Cyclin E/Cdk2 Activity Prevents Endoreduplication after Mitotic Spindle Disruption

  1999cited by this paper
• The INK4 family of cell cycle inhibitors in cancer

  1999cited by this paper
• bcl-2/bax ratio as a predictive marker for therapeutic response to radiotherapy in patients with prostate cancer.

  1998cited by this paper
• Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis.

  1998cited by this paper
• p53 Activates the CD95 (APO-1/Fas) Gene in Response to DNA Damage by Anticancer Drugs

  1998cited by this paper
• Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5.

  1997cited by this paper
• Cell and molecular biology : concepts and experiments / Gerald Karp

  1996cited by this paper
• Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence

  1996cited by this paper
• Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo.

  1995cited by this paper
• Expression of bcl-xL can confer a multidrug resistance phenotype.

  1995cited by this paper
• Sequence-specific transcriptional activation is essential for growth suppression by p53.

  1994cited by this paper
• Highly frequent homozygous deletion of the p16 gene in esophageal cancer cell lines.

  1994cited by this paper
• Effect of suramin on p34cdc2 kinase in vitro and in extracts from human H69 cells: evidence for a double mechanism of action.

  1994cited by this paper
• Wild-type p53 mediates positive regulation of gene expression through a specific DNA sequence element.

  1992cited by this paper
• Growth inhibition with reversible cell cycle arrest of carcinoma cells by flavone L86-8275.

  1992cited by this paper
• Wild-type p53 activates transcription in vitro

  1992cited by this paper

• Signaling pathways and molecular mechanisms of lupeol in colorectal cancer: A comprehensive review

  2026cites this paper
• Ethnomedicinal versus random testing for antineoplastic activity; A review of South African indigenous and naturalised plants

  2025cites this paper
• Genotoxic and cytotoxic potential of essential oils from plants of the Cerrado and southern Pantanal of Mato Grosso do Sul, Brazil.

  2025cites this paper
• Advances in In Vitro Modeling of Cancer‐Stromal Interactions: From Fundamental Insights to Translational Applications

  2025cites this paper
• Preclinical research and potential clinical application of traditional Chinese medicine in cancer treatment: take Astragalus and Dioscorea opposita as an example

  2025cites this paper
• Multiplatform metabolomics and chemometrics reveals anticancer metabolites in Clinacanthus nutans against nasopharyngeal carcinoma

  2025cites this paper
• Lupeol: an updated review utilizing AI-assisted predictive tools for enhanced therapeutic insights into lupeol’s potential for alopecia management

  2025cites this paper
• An updated review deciphering the anticancer potential of pentacyclic triterpene lupeol and its nanoformulations

  2025cites this paper
• Therapeutic Potential of Phytochemicals as Adjuvants in Head and Neck Cancer.

  2025cites this paper
• Design, Synthesis, and Antitumor Activity Evaluation of Lupeol-3-indazole Derivatives

  2025cites this paper
• Lupeol: A dietary and medicinal triterpene with therapeutic potential.

  2024cites this paper
• In-depth analysis of lupeol: delving into the diverse pharmacological profile

  2024cites this paper
• Research Progress on the Anti-Cancer Effects of Astragalus membranaceus Saponins and Their Mechanisms of Action

  2024cites this paper
• CDKN2A inhibited ferroptosis through activating JAK2/STAT3 pathway to modulate cisplatin resistance in cervical squamous cell carcinoma

  2024cites this paper
• Exploring the Therapeutic Potential of Lupeol: A Review of Its Mechanisms, Clinical Applications, and Advances in Bioavailability Enhancement.

  2024cites this paper
• Prognostic implication of cuproptosis related genes associates with immunity in Ewing's sarcoma

  2023cites this paper
• Lupeol synergizes with 5-fluorouracil to combat c-MET/EphA2 mediated chemoresistance in triple negative breast cancer

  2023cites this paper
• Lupeol and Paclitaxel cooperate in hindering hypoxia induced vasculogenic mimicry via suppression of HIF-1α-EphA2-Laminin-5γ2 network in human oral cancer

  2022cites this paper
• Molecular pharmacology and therapeutic advances of the pentacyclic triterpene lupeol.

  2022cites this paper
• Lupeol triggers oxidative stress, ferroptosis, apoptosis and restrains inflammation in nasopharyngeal carcinoma via AMPK/NF-κB pathway

  2022cites this paper
• Molecular pathways modulated by phytochemicals in head and neck cancer

  2022cites this paper
• Identification and Analysis of Senescence-Related Genes in Head and Neck Squamous Cell Carcinoma by a Comprehensive Bioinformatics Approach

  2022cites this paper
• Molecular docking analysis of lupeol with different cancer targets

  2022cites this paper
• Investigation of Lupeol as Anti-Melanoma Agent: An In Vitro-In Ovo Perspective

  2021cites this paper
• Antiophidic activity of the secondary metabolite lupeol isolated from Zanthoxylum monogynum.

  2021cites this paper
• Transcriptome analysis and differentially expressed gene screening for hypoxic-ischemic brain damage in rats treated with acupuncture

  2021cites this paper
• Phytochemicals as Potential Chemopreventive and Chemotherapeutic Agents for Emerging Human Papillomavirus–Driven Head and Neck Cancer: Current Evidence and Future Prospects

  2021cites this paper
• Low expression of CIP4 in predicting worse overall survival: A potential biomarker for laryngeal cancer

  2021cites this paper
• Patient-Derived Explants as a Precision Medicine Patient-Proximal Testing Platform Informing Cancer Management

  2021cites this paper
• Bioactive compounds from Cudrania tricuspidata: A natural anticancer source

  2020cites this paper
• Traditional Chinese medicine targeting cancer stem cells as an alternative treatment for hepatocellular carcinoma.

  2020cites this paper
• Chemosensitisation of Therapy Resistant Tumors: Targeting Multiple cell Signaling pathways by Lupeol, A Pentacyclic Triterpene.

  2020cites this paper
• Patient-derived explants (PDEs) as a powerful preclinical platform for anti-cancer drug and biomarker discovery

  2020cites this paper
• Development of a patient-derived explant model for prediction of drug responses in endometrial cancer.

  2020cites this paper
• Lupeol and its derivatives as anticancer and anti-inflammatory agents: molecular mechanisms and therapeutic efficacy.

  2020cites this paper
• Ex Vivo Culture Models to Indicate Therapy Response in Head and Neck Squamous Cell Carcinoma

  2020cites this paper
• Identification of prognostic aging-related genes associated with immunosuppression and inflammation in head and neck squamous cell carcinoma

  2020cites this paper
• CDKN2A inhibits cell proliferation and invasion in cervical cancer through LDHA-mediated AKT/mTOR pathway

  2020cites this paper
• Chemical composition and broad-spectrum anthelmintic activity of a cultivar of toothache plant, Acmella oleracea, from Mizoram, India

  2020cites this paper
• Mapping Pharmacological Network of Multi-Targeting Litchi Ingredients in Cancer Therapeutics

  2020cites this paper
• Relevance of humanized three-dimensional tumor tissue models: a descriptive systematic literature review

  2020cites this paper
• Reversing effect of Lupeol on vasculogenic mimicry in murine melanoma progression.

  2019cites this paper
• Preclinical Organotypic Models for the Assessment of Novel Cancer Therapeutics and Treatment.

  2019cites this paper
• Assessment of composition and biological activity of Arctium lappa leaves extracts obtained with pressurized liquid and supercritical CO2 extraction

  2019cites this paper
• Metformin enhances gefitinib efficacy by interfering with interactions between tumor-associated macrophages and head and neck squamous cell carcinoma cells

  2019cites this paper
• Fibroblast growth factor receptor 1 and 3 expression is associated with regulatory PI3K/AKT kinase activity, as well as invasion and prognosis, in human laryngeal cancer

  2018cites this paper
• Absorption and distribution of lupeol in CD-1 mice evaluated by UPLC-APCI+ -MS/MS.

  2018cites this paper
• Radio-sensitization of head and neck cancer cells by a combination of poly(I:C) and cisplatin through downregulation of survivin and c-IAP2

  2018cites this paper
• Identification of novel gene expression signature in lung adenocarcinoma by using next-generation sequencing data and bioinformatics analysis

  2017cites this paper
• Role of β-catenin in cisplatin resistance, relapse and prognosis of head and neck squamous cell carcinoma

  2017cites this paper